Predictive Biomarkers in Metastatic Colorectal Cancer Patients Treated With Bevacizumab: A Turkish Oncology Group (TOG) Study.

Hacan BA, Sonugür FG, Öçal M, Babahan C, Abgarmi S, Arslan ÜY, Şendur MA, Demirkazık A, Utkan G, Akbulut H

Open source

DOI
10.1002/ijc.70588
Published
2026 Oct 15
Container
International journal of cancer
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ijc.70588,
  title = {Predictive Biomarkers in Metastatic Colorectal Cancer Patients Treated With Bevacizumab: A Turkish Oncology Group (TOG) Study.},
  author = {Hacan BA and Sonugür FG and Öçal M and Babahan C and Abgarmi S and Arslan ÜY and Şendur MA and Demirkazık A and Utkan G and Akbulut H},
  year = {2026},
  journal = {International journal of cancer},
  doi = {10.1002/ijc.70588},
  url = {https://doi.org/10.1002/ijc.70588}
}

RIS

TY  - JOUR
TI  - Predictive Biomarkers in Metastatic Colorectal Cancer Patients Treated With Bevacizumab: A Turkish Oncology Group (TOG) Study.
AU  - Hacan BA
AU  - Sonugür FG
AU  - Öçal M
AU  - Babahan C
AU  - Abgarmi S
AU  - Arslan ÜY
AU  - Şendur MA
AU  - Demirkazık A
AU  - Utkan G
AU  - Akbulut H
PY  - 2026
JO  - International journal of cancer
DO  - 10.1002/ijc.70588
UR  - https://doi.org/10.1002/ijc.70588
ER  - 

APA

BA, H., FG, S., M, Ö., C, B., S, A., ÜY, A., MA, Ş., A, D., G, U., & H, A. (2026). Predictive Biomarkers in Metastatic Colorectal Cancer Patients Treated With Bevacizumab: A Turkish Oncology Group (TOG) Study.. International journal of cancer. https://doi.org/10.1002/ijc.70588

Source records